Development of the gut microbiome in early life

Abstract

New findings: What is the topic of this review? The importance of the early life gut microbiome, with a focus on preterm infants and microbially related diseases. Current techniques to study the preterm gut microbiome are appraised, and the potential of recent methodological advancements is discussed. What advances does it highlight? Recent findings in the field achieved by the application of advanced technologies, the applicability of intestinally derived organoid models to study host-microbiome interactions in the preterm gut, and recent developments in enhancing the physiological relevance of such models. Preterm intestinally derived organoids may provide novel insights into the mechanisms underlying preterm disease, as well as diagnosis and treatment opportunities. These models have huge translational potential, offering a step towards precision medicine.

Abstract: Accumulating evidence affirms the importance of the gut microbiome in both health and disease. In early life, there exists a critical period in which the composition of gut microbes is particularly malleable and subject to a wide range of influencing factors. Disturbances to microbial communities during this time may be beneficial or detrimental to short and long-term health outcomes. For infants born prematurely, naïve immune systems, immature gastrointestinal tracts and additional clinical needs put this population at high risk of abnormal microbial colonisation, resulting in increased susceptibility to diseases including necrotising enterocolitis (NEC) and late-onset sepsis (LOS). Traditional cell culture methods, gnotobiotic animals, molecular sequencing techniques (16S rRNA gene sequencing and metagenomics) and advanced 'omics' technologies (transcriptomics, proteomics and metabolomics) have been fundamental in exploring the associations between diet, gut microbes, microbial functions and disease. Despite significant investment and ongoing research efforts, prevention and treatment strategies in NEC and LOS remain limited. Recent endeavours have focused on searching for new, more physiologically relevant models to simulate the preterm intestine. Preterm intestinally derived organoids represent a promising in vitro approach in the study of host-microbiome interactions in the preterm infant gut, offering new and exciting possibilities in this field.

Keywords: early life; gut microbiome; microbiota; organoids; preterm infant.

FIGURE 1

Roles of the infant gut microbiota (left) and potential short‐ and long‐term consequences of early life microbial dysbiosis (right), which may be common in preterm infants. NEC, necrotising enterocolitis. Image was created using Servier Medical Art (http://smart.servier.com/)

FIGURE 2

Development of the gut microbiota throughout life. Relative abundances of bacterial phyla (Proteobacteria, Actinobacteria, Firmicutes, Bacteroidetes and other) are depicted for preterm infants (at birth and at discharge from hospital), term infants, children, adults and older adults. Infants’ relative abundances were derived from work by (Masi et al., ; Stewart et al., ; Vaiserman et al., 2017). Image was created using Servier Medical Art (http://smart.servier.com/)